These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 674341)

  • 1. Long acting methadone formulations.
    Choulis NH; Abellana-Intaphan L; Narang PK
    Pharmazie; 1978 May; 33(5):289-91. PubMed ID: 674341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long acting methadone formulation. Part 3: Preparation and in vivo evaluation of tablets containing methadone salts and methadone-naloxone combinations.
    Choulis NH; Abellana-Intaphan L
    Pharmazie; 1977; 32(8-9):518-9. PubMed ID: 594119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained release methadone salts and methadone-naloxone mixtures. Part 2: In vitro studies of methadone release.
    Choulis NH; Sandhu BS; Abellana-Intaphan LA
    Pharmazie; 1977 May; 32(5):287-8. PubMed ID: 561410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long acting methadone.
    Choulis NH; Papadopoulos H; Choulis M
    Pharmazie; 1976 Jul; 31(7):466-70. PubMed ID: 988594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratio.
    Bell J; Shearer J; Ryan A; Graham R; Korompay K; Rizzo S; Sindhusake D; Somogyi AA
    Exp Clin Psychopharmacol; 2009 Jun; 17(3):146-53. PubMed ID: 19586229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone and naloxone in combination (Naldone) for the treatment of heroin addicts.
    Caruso FS; Gordon M; Pachter IJ
    Proc Natl Conf Methadone Treat; 1973; 2():1336-41. PubMed ID: 4215978
    [No Abstract]   [Full Text] [Related]  

  • 7. An ultra-low dose of naloxone added to lidocaine or lidocaine-fentanyl mixture prolongs axillary brachial plexus blockade.
    Movafegh A; Nouralishahi B; Sadeghi M; Nabavian O
    Anesth Analg; 2009 Nov; 109(5):1679-83. PubMed ID: 19843808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naproxen-Eudragit microspheres: screening of process and formulation variables for the preparation of extended release tablets.
    Zaghloul AA; Faltinek J; Vaithiyalingam SR; Reddy IK; Khan MA
    Pharmazie; 2001 Apr; 56(4):321-4. PubMed ID: 11338673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis.
    Qureshi J; Ahuja A; Baboota S; Chutani K; Jain S; Ali J
    Methods Find Exp Clin Pharmacol; 2009; 31(1):15-23. PubMed ID: 19357794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies with naloxone/methadone in a ratio of 1:20.
    Bloom WA; Sudderth EW; Marcello L
    Proc Natl Conf Methadone Treat; 1973; 2():1342-9. PubMed ID: 4612372
    [No Abstract]   [Full Text] [Related]  

  • 11. Insoluble salts and salt complexes of cyclazocine and naloxone.
    Gray AP; Robinson DS
    Adv Biochem Psychopharmacol; 1973; 8(0):555-68. PubMed ID: 4800171
    [No Abstract]   [Full Text] [Related]  

  • 12. Eudragit E as excipient for production of granules and tablets from Phyllanthus niruri L spray-dried extract.
    Pereira de Souza T; Martínez-Pacheco R; Gómez-Amoza JL; Petrovick PR
    AAPS PharmSciTech; 2007 Apr; 8(2):Article 34. PubMed ID: 17622112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oral absorption of methadone from a new parenterally nonabusable tablet.
    Van Harken DR; Monteleone P; Caruso FS; Bloom WA
    Proc Natl Conf Methadone Treat; 1973; 2():1355-61. PubMed ID: 4808288
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone-methadone combination for the treatment of opiate dependence.
    Parwatikar S; Knowles RR
    Proc Natl Conf Methadone Treat; 1973; 2():1350-4. PubMed ID: 4612373
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tilidine/naloxon retard in long-term administration in chronic pain and multimorbidity. Multicenter study of long-term tolerance and effectiveness in 2 years observation].
    Flöter T; Brunnmüller U
    Fortschr Med Orig; 2002; 120(1):29-35. PubMed ID: 14518355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
    Gohel MC; Amin AF; Patel KV; Panchal MK
    Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
    Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
    Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.